Henry Ye

Henry Ye has worked in a variety of roles in the biopharmaceutical industry since 2010. Henry began their career as an Associate Researcher at SUNY Downstate Medical Center in 2010. In 2011, they moved to Simcere Pharmaceutical Group where they worked as a Researcher in DMPK. In 2012, they joined ChinaBio, LLC as a Senior Consultant. In 2017, they became a Business Development Manager at Eddingpharm. In 2020, they were promoted to Associate Director of BD & Portfolio Management at HARBOUR BIOMED. Most recently, in 2021, they joined Phaeno Therapeutics as an Associate BD Director, and they are currently working in the same role at Reistone Biopharma.

Henry Ye received their Bachelor's Degree in Pharmaceutics from China Pharmaceutical University and their Master's Degree in Biomedical Science from Long Island University.